EDIT vs IP
Editas Medicine Inc (EDIT) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
IP does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the EDIT and IP stock pages for the full models.
Not investment advice.